| Idioma original | English (US) |
|---|---|
| Páginas (desde-hasta) | 1031-1039 |
| Número de páginas | 9 |
| Publicación | Clinical Infectious Diseases |
| Volumen | 43 |
| N.º | 8 |
| DOI | |
| Estado | Published - oct 15 2006 |
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases
Acceder al documento
Otros archivos y enlaces
Citar esto
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
En: Clinical Infectious Diseases, Vol. 43, N.º 8, 15.10.2006, p. 1031-1039.
Producción científica: Review article › revisión exhaustiva
}
TY - JOUR
T1 - Clinical research in the lay press
T2 - Irresponsible journalism raises a huge dose of doubt
AU - Anaissie, Elias J.
AU - Segal, Brahm H.
AU - Graybill, John R.
AU - Arndt, Carola
AU - Perfect, John R.
AU - Kleinberg, Michael
AU - Pappas, Peter
AU - Benjamin, Danny
AU - Rubin, Robert
AU - Aberg, Judith A.
AU - Adderson, Elisabeth E.
AU - Adler-Shohet, Felice C.
AU - Akan, Hamdi
AU - Akova, Murat
AU - Almyroudis, Nikolaos G.
AU - Alexander, Barbara D.
AU - Andes, David
AU - Arrieta, Antonio
AU - Baddley, John W.
AU - Barron, Michelle A.
AU - Belzberg, Howard
AU - Boucher, Helen W.
AU - Boyce, Thomas G.
AU - Casadevall, Arturo
AU - Chandrasekar, P. H.
AU - Cleary, John D.
AU - Cordonnier, Catherine
AU - Cornely, Oliver A.
AU - Cuenca-Estrella, Manuel
AU - Daly, Jennifer S.
AU - Daoura, Nicholas
AU - Denning, David W.
AU - DePauw, Ben
AU - De Repentigny, Louis
AU - Dignani, Maria Cecilia
AU - Dismukes, William E.
AU - Donnelly, J. Peter
AU - Donowitz, Gerald R.
AU - Dupont, Bertrand
AU - Drusano, George
AU - Ellis, Michael
AU - Espinel-Ingroff, Ana
AU - Fishman, Jay A.
AU - Fleming, Rhonda
AU - Forrest, Graeme
AU - Ghannoum, Mahmoud
AU - Goldman, Mitchell
AU - Grazziutti, Monica
AU - Greene, John H.
AU - Greenberg, Richard N.
AU - Gubbins, Paul O.
AU - Hadley, Susan
AU - Herbrecht, Raoul
AU - Hiemenz, John W.
AU - Hope, William
AU - Hospenthal, Durane R.
AU - Husain, Shahid
AU - Ito, James I.
AU - Jacobson, Robert M.
AU - Johnson, Melissa
AU - Keating, Michael R.
AU - Kett, Daniel H.
AU - Knapp, Katherine
AU - Kontoyiannis, Dimitrios P.
AU - Krcmery, Vladimir C.
AU - Larsen, Robert
AU - Laverdiere, Michel
AU - Ljungman, Per
AU - Lortholary, O.
AU - Maertens, Johan
AU - Marriott, Debbie
AU - Mattiuzzi, Gloria
AU - McGinnis, Michael R.
AU - Morris, Michele
AU - Nucci, Marcio
AU - Odds, Frank C.
AU - Pankey, George A.
AU - Patterson, Thomas
AU - Pfaller, Mike
AU - Razonable, Raymond R.
AU - Reboli, Annette C.
AU - Rinaldi, Michael G.
AU - Roberts, Glenn D.
AU - Rodriguez Tudela, Juan Luis
AU - Rotstein, Coleman
AU - Ruhnke, Markus
AU - Schuster, Mindy
AU - Shoham, Shmuel
AU - Sia, Irene G.
AU - Siebel, Nita
AU - Silviera, Fernanda
AU - Singh, Nina
AU - Sobel, Jack
AU - Solomkin, Joseph S.
AU - Sorrell, Tania C.
AU - Steinbach, William J.
AU - Temesgen, Zelalem
AU - Tortorano, Annamaria
AU - Vartivarian, Shahe
AU - Verweij, Paul
AU - Viscoli, Claudio
AU - Viviani, Maria Anna
AU - Walker, Randall C.
AU - Wheat, Joseph L.
AU - Wiley, Joseph
AU - Williamson, Peter
AU - Wingard, John R.
AU - Yu, Victor L.
AU - Zaoutis, Theoklis
N1 - Funding Information: ceived grant support from Astellas, Curagen, En-zon, Nuvelo, Orthobiotech, and Pfizer, is a consultant for Astellas, Gilead Sciences, Merck, Pfizer, and Schering Plough, and is a member of the speaker’s bureau for Astellas, Gilead Sciences, Merck, Pfizer, and Schering Plough. B.H.S. has received grant support from Astellas, is a consultant for Enzon and Schering Plough, and is a member of the speaker’s bureau for Merck and Pfizer. J.R.G. has received grant support from Aro-nex, Vicuron, Pfizer, Schering, Fujisawa, Astellas, F2G, Merck, and Indevus, is a consultant for Aro-nex, Vicuron, Pfizer, Schering, Fujisawa, Astellas, F2G, Merck, Indevus, Abbott, and Glaxo-SmithKline, and is a member of the speaker’s bureau for Pfizer, Schering, and F2G. C.A. is a stockholder in Merck. J.R.P. has received grant support from Merck, Enzon, Astellas, Schering Plough, and Pfizer and is a consultant for Merck, Enzon, As-tellas, Schering Plough, and Pfizer. M.K. has received grant support from Pfizer and is a member of the speaker’s bureau for Pfizer and Enzon. D.B. has received grant support from Astellas, Med-Immune, Pediatrix, Rocketasher Research, Astra Zeneca, Johnson & Johnson, Pfizer, and Vicuron. J.A.A. has received grant support from Bristol My-ers Squibb, Gilead, Abbott, Roche, Berlex Labs, Merck, GlaxoSmithKline, and Tibotec and is a consultant for Bristol Myers Squibb, Gilead, Abbott, GlaxoSmithKline, and Boehringer Ingelheim. B.D.A. has received grant support from Astellas and Enzon, is a consultant for Astellas, Pfizer, Sch-ering Plough, Enzon, Bristol Myers Squibb/Eisai Medical Research, Cubicin, Merck, Novartis,Phar- macia, Roche, Vircuron, and Viropharma, and is a member of the speaker’s bureau for Astellas, Pfizer, Schering Plough, and OrthoBiotec. D.A. has received grant support from Astellas, Pfizer, En-zon, Schering, GlaxoSmithKline, and Merck, is a consultant for Pfizer, Schering Plough, and Merck, and is a member of the speaker’s bureau for Pfizer and Merck. J.W.B. has received grant support from Merck and Astellas, is a consultant for Merck, and is a member of the speaker’s bureau for Enzon, Merck, and Pfizer. M.A.B. has received grant support from Astellas, Cubist, Genzyme, and Merck, is a consultant for Astellas, Abbott, Pfizer, Merck, and Schering Plough, and is a member of the speaker’s bureau for Astellas, Abbott, Pfizer, Merck, and Schering Plough. H.W.B. is a consultant for Cubist Pharmaceuticals, Pfizer, As-preva, Aspreva Pharmaceuticals, and Schering Plough, is a member of the speaker’s bureau for Cubist Pharmaceuticals, Pfizer, Aspreva, Aspreva Pharmaceuticals, and Schering Plough, and is a stock holder in Cubist. T.G.B. is a member of the speaker’s bureau for Abbott, MedImmune, Pfizer, and Sanofi-Pasteur. A.C. has received grant support from Pfizer and Energy Dynamics and is a consultant for Pfizer, Merck, Wyeth, Bioveris, and Energy Dynamics. O.A.C. has received grant support from Astellas, Basilea, Gilead, Pfizer, Merck, Schering Plough, and Vicuron, is a consultant for Astellas, Basilea, Gilead, Pfizer, Merck, Nektar, and Schering Plough, and is a member of the speaker’s bureau for Astellas, Gilead, Merck, and Schering Plough. M.C.-E. has received grant support from Pfizer, Merck, Schering Plough, and Gilead and is a member of the speaker’s bureau for Gilead, Merck, Pfizer, and Schering Plough. J.S.D. has received grant support from Merck and Schering Plough. L.d.R. has received grant support from the Canadian Institute of Health. M.C.D. is a member of the speaker’s bureau for Pfizer. W.E.D. has received grant support from Merck and Astellas, is a consultant for Astellas and Pfizer, and is a member of the speaker’s bureau for Astellas, Pfizer, and Merck. G.R.D. has received grant support from Fujisawa/Astellas, Merck, and Optimer. B.D. has received grant support from Astellas, Pfizer, Sch-ering, and Merck, is a consultant for Bio Alliance Pharma, and is a member of the speaker’s bureau for Astellas, Schering, and Merck. M.E. has received grant support from Merck and Gilead and is a member of the speaker’s bureau for Merck and Gilead. A.E.-I. has received grant supportfrom Pfizer and Schering Plough. J.A.F. has received grant support from Astellas and Roche, is a consultant for Gilead, Merck, Biogen-IDEC, Hoffman LaRoche, Athelas Primera, FDA/CBER–Xenotransplantation, and is a member of the speaker’s bureau for the Immune Tolerance Network–National Institute of Allergy and Infectious Diseases–National Institutes of Health Transplantation Trials. R.F. has received research support from Cubicin and GlaxoSmthKline, is a consultant for Pfizer, Elan Pharmaceuticals, Abbott, and GlaxoSmth-Kline, and is a member of the speaker’s bureau for Merck, Pfizer, and GlaxoSmthKline. G.F. has received research support from Astellas, Cubist, and Pfizer and is a member of the speaker’s bureau for Astellas, Cubist, Pfizer, and Schering Plough. M. Ghannoum has received grant support from Astellas, Enzon, Indevus, Pfizer, Merck, Helix BioAlliance, Novartis, Anacor, Nex Med, Maruho, and Great Lakes Pharmaceuticals, is a consultant for Stiefel, Pfizer, Schering Plough, Novartis , and Enzon, and is a member of the speaker’s bureau for Astellas, Merck, Pfizer, Schering Plough, and Enzon. M. Goldman has received research support from Pfizer and Glaxo, is a consultant for Gilead Sciences, Schering Plough, and Merck, and is a member of the speaker’s bureau for Merck. J.N.G. has received research support from Pfizer and Sch-ering Plough. R.N.G. has received researchsupport from Acambis, Vaxgen, Dynport, Tibotec, Merck, Schering Plough, VirXsys, GlaxoSmthKline, Boer-inger-Ingelheim, Bristol Myers Squibb, and VA, is a consultant for Acambis, and is a member of the speaker’s bureau for Schering Plough. P.O.G. has received research support from Astellas and Pfizer, is a consultant for Astellas and Merck, and is a member of the speaker’s bureau for Astellas and Merck. S.H. has received research support from Pfizer, is a consultant for Astellas, Schering Plough, and Domantis, and is a member of the speaker’s bureau for Astellas, Merck, Pfizer, Schering Plough, and Enzon. R.H. has received research support from Pfizer, is a consultant for ACE Biosciences, Astellas, Gilead Sciences, Merck, Pfizer, Schering Plough, and Zeneus, and is a member of the speaker’s bureau for Gilead Sciences, Pfizer, and Schering Plough. J.W.H. has received research support from Astellas, Curagen, and Schering Plough, is a consultant for Astellas, Pfizer, Three Rivers, and Schering Plough, and is a member of the speaker’s bureau for Astellas, Merck, and Pfizer. W.H. is associated with Astellas. D.R.H. has received grant support from Merck, Pfizer, and Schering Plough and is a member of the speaker’s bureau for Merck and Pfizer. J.I.I. is a consultant for Enzon, Pfizer, and Schering Plough and is a member of the speaker’s bureau for Astellas, En-zon, Pfizer, and Schering Plough. R.M.J. has received grant support from Merck, VaxGen, BioPort, and Chiron (Novartis). D.H.K. has received grant support from Pfizer, Wyeth, Merck, Astellas, and Hopira, is a consultant for Pfizer, Enzon, Cubist, Wyeth, Astellas, Lilly, Sanofi Av-entis, and GlaxoSmithKline, and is a member of the speaker’s bureau for Pfizer, Cubist, Wyeth, Merck, Astellas, Lilly, Sanofi Aventis, and Glaxo. K.K. has received grant support from Merck and Schering Plough. D.P.K. has received grant support from Schering Plough, Pfizer, Astellas, Enzon, and Merck. R.L. has received grant support from Merck, Incyte Abbott, Boeringer Ingleheim, and Gilead Sciences. M.L. has received grant support from Astellas, Pfizer, Merck, Schering Plough, BioRad Laboratories, and Vicuron, is a consultant for Pfizer Canada, Astellas Canada, Merck Frosst Canada, and Schering Canada, and is a member of the speaker’s bureau for Pfizer Canada, Astellas Canada, and Merck Frosst Canada. P.L. is a consultant for Gilead Sciences and a member of the speaker’s bureau for Zeneus Pharma. J.M. has received grant support from Pfizer, Bio-Rad, and MSD, is a consultant for Astellas, Gilead Sciences, Funding Information: Nektar, Pfizer, MSD, and Schering Plough, and is a member of the speaker’s bureau for Astellas, Gilead Sciences, Merck, Pfizer, Schering Plough, MSD, and Bio-Rad. G.M. has received grant support from Astellas and MGI and is a member of the speaker’s bureau for Astellas, Merck, and Pfizer. M.R.M. is a member of the speaker’s bureau for Schering Plough. M.M. has received grant support from Pfizer and Merck, is a consultant for Astellas, Enzon, and Pfizer, and is a member of the speaker’s bureau for Astellas, Cubist, and En-zon. M.N. has received grant support from As-tellas, Enzon, Merck, and Schering Plough, is a consultant for Gilead Sciences, Pfizer, and Merck, and is a member of the speaker’s bureau for Gilead Sciences, Merck, and Pfizer Major. F.C.O. has received grant support from Merck, MDS UK, Johnson & Johnson, Syngenta, and Italfarmaco, is a consultant for Bristol Myers Squibb, Gilead Sciences, Italfarmco, Johnson & Johnson, Merck, Oxford Glycosciences, Pfizer, Schering Plough, Syn-genta, Tibotec, and Vicuron, is a member of the speaker’s bureau for Astellas, Gilead Sciences, Merck, Pfizer, and Schering Plough, and is a stockholder in Johnson & Johnson. T.P. has received grant support from Astellas, Enzon, Pfizer, Nektar, Merck, and Schering Plough, is a consultant for Astellas, Merck, Pfizer, Schering Plough, Affinium Pharmaceuticals, Basilea, Diversa, Eisai, Uriach, MediciNova, Microbia, Nektar, Rib-X Pharmaceuticals, Human Genome Sciences, and Coge-nesys, and is a member of the speaker’s bureau for Astellas, Merck, Pfizer, and Schering Plough. R.R.R. has received grant support from Roche Laboratories. A.C.R. has received grant support from Merck, Cadence, and Optima, is a consultant for Pfizer and Astellas, and is a member of the speaker’s bureau for Pfizer and Merck. J.L.R.T.. has received grant support from Pfizer, Merck, Schering Plough, and Gilead and is a member of the speaker’s bureau for Gilead, Merck, Pfizer, and Schering Plough. C.R. has received grant support from Astellas, Johnson & Johnson, Pfizer, Wyeth, and Merck and is a consultant for Astellas, Bayer, Merck, Pfizer, and Wyeth. M.R. has received grant support from Pfizer, is a consultant for Astellas, Gilead Sciences, Pfizer, Shering Plough, Janssen, and Merck/MSD, and is a member of the speaker’s bureau for Gilead, Merck, Pfizer, and Schering Plough. M.S. has received grant support from As-tellas, Enzon, Pfizer, and Merck and is a member of the speaker’s bureau for Enzon and Pfizer. S.S. has received grant support from Astellas, Enzon, Merck, and AdvanDx, is a consultant for Pfizer, Astellas, Merck, and Enzon, is a member of the speaker’s bureau for Pfizer, Roche, Merck, Enzon, and AdvanDx, and is a stockholder in Medonyx. N.S. is a consultant for Enzon and is a member of the speaker’s bureau for Astellas, Pfizer, and Enzon. N.S. has received grant support from Sch- ering Plough and Enzon. W.J.S. has received grant support from Astellas and Merck and is a member of the speaker’s bureau for Schering Plough, As-tellas, and Pfizer. Z.T. has received grant support from Abbott, Gilead Sciences, and Bristol Myers Squibb. C.V. has received grant support from Gil-ead Sciences and Wyeth, is a consultant for Pfizer, and is a member of the speaker’s bureau for Gilead Sciences. M.A.V. is a member of the speaker’s bureau for Gilead Sciences. J.L.W. is a consultant for BioRad and a stockholder in Miravista Diagnostics and MiraBella Technologies. J.R.W. has received grant support from Merck and Schering Plough, is a consultant for Merck, Nektar, Pfizer, and Sch-ering Plough, and is a member of the speaker’s bureau for Merck, Pfizer, and Schering Plough. V.L.Y. has recieved grant support from Pfizer and OrthoMcNeil. T.Z. has received grant support from Merck, Pfizer, and Elan and is a consultant for Enzon and Zeneus. All other authors: no conflicts.
PY - 2006/10/15
Y1 - 2006/10/15
UR - https://www.scopus.com/pages/publications/33750357776
UR - https://www.scopus.com/pages/publications/33750357776#tab=citedBy
U2 - 10.1086/509116
DO - 10.1086/509116
M3 - Review article
C2 - 16983616
AN - SCOPUS:33750357776
SN - 1058-4838
VL - 43
SP - 1031
EP - 1039
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
IS - 8
ER -